glp 1 and synthroid GLP-1 with Hypothyroidism: Safety, TSH Monitoring & Provider G... – PlexusDx Glucagon-like peptide-1 receptor agonists and

Effects of semaglutide on albuminuria and kidney function in people with overweight or obesity with or without type 2 diabetes: exploratory analysis from the STEP 1, 2, and 3 trials

I dont know if its in my head or if it really is something thats helping, but Im not going to stop wearing them. Hargens, the 34-year-old whos long struggled with her weight, is similarly unbothered by the concept of her experience with the patches being chalked up to the placebo effect

Am J Physiol Endocrinol Metab 310: E505E514, 2016

The prevalence of these effects is currently unknown, and they are not commonly listed as adverse effects in US prescribing information for most agents

Safe GLP-1 therapy generally requires: Baseline metabolic laboratory testing Medication review Screening for thyroid and pancreatic history Ongoing clinical follow-up Lowering the dose does not eliminate contraindications